Manufacturing Mesenchymal Stromal Cells in a Microcarrier-Microbioreactor Platform Can Enhance Cell Yield and Quality Attributes: Case Study for Acute Respiratory Distress Syndrome
Researchers designed and implemented a microcarrier-microbioreactor approach to cell therapy manufacturing, specific to anchorage-dependent cells such as MSCs.